MedTrace Logo

Community Pharmacy Assisting in Total Cardiovascular Health

NCT01509014 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2250

Last updated 2012-01-12

No results posted yet for this study

Summary

Despite proven benefits in reducing morbidity and mortality, many patients become nonadherent to statin therapy within the first year of starting. Due to their accessibility and frequent patient contact, pharmacists are well-positioned to improve medication adherence.

The purpose of this study is to determine whether a simple intervention by community pharmacists can improve statin adherence in new statin users.

Conditions

  • Statin Therapy
  • Adherence

Interventions

BEHAVIORAL

CPATCH intervention to support statin adherence

Routine identification of new statin users (first year of therapy), consistent assessment of barriers to adherence at every dispensation for these patients, reassurance about efficacy and safety, and proactive response to identified adherence barriers.

Sponsors & Collaborators

  • Ministry of Health, Saskatchewan

    collaborator OTHER

  • Merck Frosst Canada Ltd.

    collaborator INDUSTRY

  • University of Saskatchewan

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-03-31
Primary Completion
2011-11-30
Completion
2012-01-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01509014 on ClinicalTrials.gov